Ticker
AVO.LSE

Price
-
Stock movement up
+- (%)
Company name
Advanced Oncotherapy Plc
Exchange
(LSE
,
Currency
GBX
)
Sector
Healthcare >
Medical Devices
Market cap
1.03B
Ent value
1.12B
Price/Sales
-
Price/Book
17.10
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-9.72%
1 year return
-91.44%
3 year return
-58.01%
5 year return
-47.33%
10 year return
-26.28%
Last updated: 2024-05-25

DIVIDENDS

AVO.LSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book17.10
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count537.48M
EPS (TTM)-
FCF per share (TTM)-0.06

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)0.00
Net income (TTM)0.00
EPS (TTM)-
EPS (1y forward)-4.50

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.51M
Net receivables847.71K
Total current assets32.78M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets153.17M
Accounts payable11.53M
Short/Current long term debt59.74M
Total current liabilities25.95M
Total liabilities92.65M
Shareholder's equity60.52M
Net tangible assets-14.96M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-27.23M
Capital expenditures (TTM)1.79M
Free cash flow (TTM)-29.01M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-33.26%

STOCK INFORMATION

Downside potential

Loading...
Downside potential data
AVO.LSES&P500
Current price drop from All-time high-99.81%-7.21%
Highest price drop-99.81%-56.47%
Date of highest drop30 Jun 20239 Mar 2009
Avg drop from high-86.73%-11.31%
Avg time to new high633 days13 days
Max time to new high3792 days1805 days
COMPANY DETAILS
AVO.LSE (Advanced Oncotherapy Plc) company logo
Marketcap
1.03B
Marketcap category
Small-cap
Description
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Employees
174
Investor relations
-
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found